GM-CSF as a therapeutic target in inflammatory diseases

Area of Science:

• Immunology
• Hematology
• Pharmacology

Background:

• Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a hematopoietic growth factor used clinically for neutropenia.
• Emerging evidence highlights GM-CSF's pro-inflammatory role in Th17-driven autoimmune diseases.

Purpose of the Study:

• To review the development of GM-CSF antagonists for autoimmune disease treatment.
• To discuss recent clinical trial outcomes for these novel agents.

Main Methods:

• Literature review of GM-CSF's role in autoimmunity.
• Analysis of clinical trial data for GM-CSF antagonists.

Main Results:

• GM-CSF antagonists are being developed based on its inflammatory functions.
• Early clinical trials are exploring their use in conditions like rheumatoid arthritis.

Conclusions:

• GM-CSF antagonists represent a potential therapeutic strategy for autoimmune inflammatory diseases.
• Further clinical investigation is warranted to establish their safety and efficacy.